Label: CONTINUOUS CORRECTION CREAM- homosalate 10% octisalate 4.9% octocrylene 4% cream

  • NDC Code(s): 84203-003-01
  • Packager: Baxter of California, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 19, 2024

If you are a consumer or patient please visit this version.

  • Active ingredients

    Homosalate 10% Octisalate 4.9% Octocrylene 4%

  • Purpose

    Sunscreen

  • Uses

    - helps prevent sunburn - if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

  • Warnings

    For external use only

    Flammable until dry. Do not use near fire, flame or heat.

    Do not use

    on damaged or broken skin

    When using this product

    keep out of eyes. Rinse with water to remove.

    Stop use and ask a doctor if

    rash occurs

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    For sunscreen use: ● apply liberally 15 minutes before sun exposure ● reapply at least every 2 hours ● use a water resistant sunscreen if swimming or sweating ● Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: ● limit time in the sun, especially from 10 a.m. – 2 p.m. ● wear long-sleeved shirts, pants, hats, and sunglasses ● children under 6 months of age: Ask a doctor

  • Other information

    protect the product in this container from excessive heat and direct sun

  • Inactive ingredients

    water, dimethicone, propanediol, alcohol denat., synthetic fluorphlogopite, niacinamide, vinyl dimethicone/methicone silsesquioxane crosspolymer, caffeine, tocopherol, scutellaria baicalensis root extract, PEG-30 dipolyhydroxystearate, aluminum hydroxide, magnesium sulfate, disodium stearoyl glutamate, disteardimonium hectorite, polyglyceryl-4 diisostearate/polyhydroxystearate/sebacate, phenoxyethanol, may contain: titanium dioxide, iron oxides

  • Questions or comments?

    1-877-900-6700 Monday - Friday (9 a.m. - 5 p.m. EST)

  • PRINCIPAL DISPLAY PANEL

    cccream

  • INGREDIENTS AND APPEARANCE
    CONTINUOUS CORRECTION CREAM 
    homosalate 10% octisalate 4.9% octocrylene 4% cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84203-003
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE100 mg  in 1 mL
    OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE40 mg  in 1 mL
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE49 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM POTASSIUM ALUMINOSILICATE FLUORIDE (UNII: YK3DC63Y5M)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    SCUTELLARIA BAICALENSIS ROOT (UNII: 7J95K7ID2S)  
    PEG-30 DIPOLYHYDROXYSTEARATE (UNII: 9713Q0S7FO)  
    DISODIUM STEAROYL GLUTAMATE (UNII: 45ASM2L11M)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    WATER (UNII: 059QF0KO0R)  
    ALCOHOL (UNII: 3K9958V90M)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    CAFFEINE (UNII: 3G6A5W338E)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84203-003-011 in 1 CARTON03/29/2024
    130 mL in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02003/29/2024
    Labeler - Baxter of California, LLC (031183172)
    Establishment
    NameAddressID/FEIBusiness Operations
    L'Oreal USA Products, Inc.624244349manufacture(84203-003)